+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By End-Use, By Product, By Type (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 106 Pages
  • January 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5928518
The Asia Pacific Negative Pressure Wound Therapy Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030).

NPWT has proven highly effective in managing chronic wounds, including diabetic ulcers, venous ulcers, and pressure ulcers. The therapy promotes angiogenesis and accelerates granulation tissue formation, addressing the challenges of slow-healing chronic wounds. Following various surgical procedures, patients are at risk of complications like infections and delayed wound healing. NPWT is extensively used in post-surgical wound care to enhance tissue perfusion, reduce edema, and expedite healing. It is applied in surgeries ranging from orthopedic to abdominal and cardiovascular surgeries.

NPWT plays a crucial role in the management of traumatic injuries and acute wounds, such as lacerations, abrasions, and crush injuries. The therapy assists in removing excess exudate, promotes tissue regeneration, and lowers the risk of infection, contributing to optimal wound healing outcomes. Burn wounds pose unique challenges in terms of tissue damage and infection risk. NPWT has emerged as a valuable tool in burn wound therapy, creating a controlled environment that supports healing, reduces scarring, and minimizes the need for grafting. It is particularly beneficial in managing partial-thickness and full-thickness burn injuries.

As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. India has witnessed a notable increase in hospitals, ranging from small clinics to large multispecialty hospitals. Additionally, by 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Advances in healthcare, improved living conditions, and enhanced medical services have increased life expectancy in China. Thus, due to the above-mentioned factors, the market will grow significantly in this region.

The China market dominated the Asia Pacific Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $258.7 million by 2030. The Japan market is registering a CAGR of 6.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.8% during (2023 - 2030).

Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Market Report Segmentation

By End-Use
  • Hospitals
  • Homecare
  • Others
By Product
  • Conventional NPWT
  • Single-use NPWT
By Type
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Burn Wounds
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Negative Pressure Wound Therapy Market, by End-Use
1.4.2 Asia Pacific Negative Pressure Wound Therapy Market, by Product
1.4.3 Asia Pacific Negative Pressure Wound Therapy Market, by Type
1.4.4 Asia Pacific Negative Pressure Wound Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific Negative Pressure Wound Therapy Market, By End-Use
4.1 Asia Pacific Hospitals Market, By Country
4.2 Asia Pacific Homecare Market, By Country
4.3 Asia Pacific Others Market, By Country
Chapter 5. Asia Pacific Negative Pressure Wound Therapy Market, By Product
5.1 Asia Pacific Conventional NPWT Market, By Country
5.2 Asia Pacific Single-use NPWT Market, By Country
Chapter 6. Asia Pacific Negative Pressure Wound Therapy Market, By Type
6.1 Asia Pacific Pressure Ulcers Market, By Country
6.2 Asia Pacific Diabetic Foot Ulcers Market, By Country
6.3 Asia Pacific Venous Leg Ulcers Market, By Country
6.4 Asia Pacific Burn Wounds Market, By Country
6.5 Asia Pacific Others Market, By Country
Chapter 7. Asia Pacific Negative Pressure Wound Therapy Market, By Country
7.1 China Negative Pressure Wound Therapy Market
7.1.1 China Negative Pressure Wound Therapy Market, By End-Use
7.1.2 China Negative Pressure Wound Therapy Market, By Product
7.1.3 China Negative Pressure Wound Therapy Market, By Type
7.2 Japan Negative Pressure Wound Therapy Market
7.2.1 Japan Negative Pressure Wound Therapy Market, By End-Use
7.2.2 Japan Negative Pressure Wound Therapy Market, By Product
7.2.3 Japan Negative Pressure Wound Therapy Market, By Type
7.3 India Negative Pressure Wound Therapy Market
7.3.1 India Negative Pressure Wound Therapy Market, By End-Use
7.3.2 India Negative Pressure Wound Therapy Market, By Product
7.3.3 India Negative Pressure Wound Therapy Market, By Type
7.4 South Korea Negative Pressure Wound Therapy Market
7.4.1 South Korea Negative Pressure Wound Therapy Market, By End-Use
7.4.2 South Korea Negative Pressure Wound Therapy Market, By Product
7.4.3 South Korea Negative Pressure Wound Therapy Market, By Type
7.5 Singapore Negative Pressure Wound Therapy Market
7.5.1 Singapore Negative Pressure Wound Therapy Market, By End-Use
7.5.2 Singapore Negative Pressure Wound Therapy Market, By Product
7.5.3 Singapore Negative Pressure Wound Therapy Market, By Type
7.6 Malaysia Negative Pressure Wound Therapy Market
7.6.1 Malaysia Negative Pressure Wound Therapy Market, By End-Use
7.6.2 Malaysia Negative Pressure Wound Therapy Market, By Product
7.6.3 Malaysia Negative Pressure Wound Therapy Market, By Type
7.7 Rest of Asia Pacific Negative Pressure Wound Therapy Market
7.7.1 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By End-Use
7.7.2 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By Product
7.7.3 Rest of Asia Pacific Negative Pressure Wound Therapy Market, By Type
Chapter 8. Company Profiles
8.1 DeRoyal Industries, Inc.
8.1.1 Company Overview
8.2 Cork Medical, LLC
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Product Launches and Product Expansions:
8.3 3M Company
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Talley Group Ltd. (Direct Healthcare Group)
8.4.1 Company Overview
8.5 Smith & Nephew PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional and Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Molnlycke Health Care AB
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 ConvaTec Group PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 SWOT Analysis
8.8 Cardinal Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 SWOT Analysis
8.9 HARTMANN Group (Paul Hartmann AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.9.6 SWOT Analysis

Companies Mentioned

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Methodology

Loading
LOADING...